References
Kopans DB (2012) Not so fast: the use of incomplete data to devalue the role of mammography screening. Breast Cancer Res Treat. doi:10.1007/s10549-012-1966-z
Burton RC, Bell RJ, Thiagarajah G, Stevenson C (2012) Adjuvant therapy, not mammographic screening, accounts for most of the observed breast cancer specific mortality reductions in Australian women since the national screening program began in 1991. Breast Cancer Res Treat 131(3):949–955
Nystrom L, Rutqvist LE, Wall S et al (1993) Breast cancer screening with mammography: overview of Swedish randomised trials. Lancet 341(8851):973–978
Australian Institute of Health and Welfare (AIHW) & National Breast and Ovarian Cancer Centre (NBOCC) (2009) Breast cancer in Australia: an overview, 2009. Cancer series no. 50. Cat. no. CAN 46. AIHW, Canberra
National Breast Cancer Centre (NBCC) (1999) Surgical management of breast cancer in Australia. NBCC, Sydney
Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365(9472):1687–1717
Hill DJ, Giles GG, Russell IS, Collins JP, Mapperson KJ (1990) Management of primary, operable breast cancer in Victoria. Med J Aust 152(2):67–72
White V, Pruden M, Giles G et al (2004) The management of early breast carcinoma before and after the introduction of clinical practice guidelines. Cancer 101(3):476–485
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Burton, R.C., Bell, R.J. Letter in response: the value of mammography screening. Breast Cancer Res Treat 134, 1345–1346 (2012). https://doi.org/10.1007/s10549-012-2064-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-012-2064-y